LONG COVID
- The Lancet Diabetes and Endocrinology, 21 marzo 2022 | “Risks and burdens of incident diabetes in long COVID: a cohort study”
- Nature, 25 marzo 2022 | “Can drugs reduce the risk of long COVID? What scientists know so far”
- Annals of Internal Medicine, 8 marzo 2022 |“Toward Unbiased Evaluation of Postacute Sequelae of SARS- CoV-2 Infection: Challenges and Solutions for the Long Haul Ahead”
- Nature, 7 febbraio 2022 | “Long-term cardiovascular outcomes of COVID-19”
- JAMA, 24 gennaio 2022 | “Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19”
- Nature, 12 novembre 2021 | “Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status”
- MMWR, 10 settembre 2021| “Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021”
- BMJ, 26 luglio 2021 | “Long covid—mechanisms, risk factors, and management”
- Science, 30 luglio 2021 | “The road to addressing Long Covid”
- JAMA, 15 luglio 2021 | “Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents”
- Istituto Superiore Sanità, 1 luglio 2021 | “Indicazioni ad interim sui principi di gestione del Long-COVID”
- BMJ, 24 giugno 2021 | “Chronic fatigue syndrome and long covid: moving beyond the controversy”
- JAMA Network Open, 26 maggio 2021 | “Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19A Systematic Review”
- BMJ, 19 maggio 2021 | “Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study”
- The Lancet Infectious Diseases, 10 maggio 2021 | “Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study”
- The Lancet Respiratory Medicine, 5 maggio 2021 | “3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study”
- JAMA , 7 aprile 2021 | “Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers”
- The Lancet, 6 aprile 2021 | “6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records”
- BMJ -The British Medical Journal, 31 marzo 2021 | “Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study”
- Annals of Internal Medicine, 30 marzo 2021 | “Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19”
- Annals of Clinical and Trasnational Neurology, 23 marzo 2021 | “Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
- Nature Medicine, 22 marzo 2021 | “Post-acute COVID-19 syndrome”
- JAMA, 17 marzo 2021 | “Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19”
- JAMA, editoriale 17 marzo 2021 | “Outcomes for Patients Following Hospitalization for COVID-19”
- Nature Medicine, 10 marzo 2021 | “Attributes and predictors of long COVID”
- The Lancet, 5 marzo 2021 | “Long-haul COVID: heed the lessons from other infection-triggered illnesses”
- GIMBE – Evidence, 23 febbraio 2021 | “Linee guida per gestire la long term COVID-19”
- JAMA, 19 febbraio 2021 | “Sequelae in Adults at 6 Months After COVID-19 Infection”
- Peacock Lab 2021, 6 febbraio 2021 | “Long-COVID – the nightmare that won’t end – a researcher’s first hand perspective”
- COVID Reference, 24 gennaio 2021 | A review
- The Lancet, 8 gennaio 2021 | “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study”
- MAYO CLINIC, 17 novembre 2020 | “COVID-19 (coronavirus): Long-term effects”
- Science, 31 luglio 2020 | “From ‘brain fog’ to heart damage, COVID-19’s lingering problems alarm scientists”
- JAMA, 9 luglio 2020 | “Persistent Symptoms in Patients After Acute COVID-19”